Skip to main content
Scilex Holding Co logo

Scilex Holding Co — Investor Relations & Filings

Ticker · SCLX ISIN · US80880W2052 LEI · 529900SPEA2C7YTTYP45 US Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2021-08-19 Interim / Quarterly Rep…
Country US United States of America
Listing US SCLX

About Scilex Holding Co

https://www.scilexholding.com/

Scilex Holding Co. is a company focused on the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company's portfolio targets indications with high unmet medical needs and features therapies with proprietary drug delivery systems. These systems include an advanced topical patch technology for optimized drug delivery through the skin, an anti-inflammatory oral solution designed for individualized dosing in high-risk patients, and a liquid ready-to-use analgesic for migraine relief. Scilex aims to provide effective alternatives to opioid medications to improve patient quality of life.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2021
2021-08-19 English
Regulatory Filings 2021
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the quarterly report on Form 10-Q for the period ended June 30, 2021, could not be filed on time and will be filed within the prescribed deadline. The document does not contain the actual financial data or the full quarterly report but is a notification about the delay in filing the Form 10-Q. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document related to filing deadlines and does not contain substantive financial information itself.
2021-08-16 English
QUARTERLY REPORT
Interim / Quarterly Report Q1 2021
2021-07-23 English
CURRENT REPORT
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The content specifically discusses a notice of delisting due to failure to file a Quarterly Report on Form 10-Q, details about the SEC's guidance on SPAC warrants, and the company's plan to regain compliance. It also includes a press release as an exhibit. The document does not contain full financial statements or detailed financial analysis but is an announcement of a regulatory event and compliance status. Therefore, it fits the category of a Regulatory Filing (RNS) rather than a full financial report or other specific filing types.
2021-06-01 English
NOTIFICATION OF LATE FILING
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 Notification of Late Filing submitted to the SEC. It specifically states that the company, Vickers Vantage Corp. I, is notifying the SEC of a delay in filing its Form 10-Q quarterly report for the period ended March 31, 2021. The document explains the reason for the delay related to accounting treatment of warrants following an SEC staff statement. The document does not contain the actual financial data or the quarterly report itself, but rather is a notification about the late filing of the 10-Q report. According to the rules, such a notification is a Regulatory Filing (RNS) and not the actual Interim/Quarterly Report (IR).
2021-05-17 English
ANNUAL REPORT
Annual Report FY 2020
2021-03-31 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.